Sernova Corp.
SEOVF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$43.43M
Close$
$-0.04
148.5% downside
Current Fair Value
148.5% downsideOvervalued by 148.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $43.43 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.05 |
| Beta | 0.64 |
| Outstanding Shares | 377,642,509 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -3.91 |
|---|---|
| PEG | 10.32 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
September 10, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
December 18, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Sernova Corp.
8 employees
CEO: Jonathan N. Rigby
Sernova Corp. is a Canadian firm, established in 1998 and headquartered in London, that specializes in advanced regenerative medicine therapeutics and is currently in its clinical development phase. The company's primary objective is to ...